E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/27/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: LAB International to sell C$25.89 million of special warrants

By Laura Lutz

Des Moines, Oct. 27 - LAB International Inc. arranged a private placement of special warrants exchangeable for common shares of LAB Research Inc., for proceeds of C$25,891,070.

The company plans to sell 6,392,857 special warrants at C$4.05 each. Each special warrant is exercisable for one common share of LAB Research.

Desjardins Securities Inc. agreed to act as agent for the deal.

Settlement is expected on Nov. 9.

LAB is a drug development based in Laval, Quebec.

Issuer:LAB International Inc.
Issue:Special warrants exchangeable for shares of LAB Research Inc.
Amount:C$25,891,070
Special warrants:6,392,857
Price:C$4.05
Warrants:No
Agent:Desjardins Securities Inc.
Pricing date:Oct. 27
Settlement date:Nov. 9
Stock symbol:Toronto: LRI (LAB Research)
Stock price:C$4.10 at close Oct. 26 (LAB Research)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.